An in vitro technique for evaluating inhaled nasal delivery systems

S.T.P. Pharma Sciences

Volumn 12, Issue 1, 2002, Pages 75-79

  Forbes, B ^a   Lim, S ^a   Martin, G P ^a   Brown, M B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

16HBE14o; Aerosol; Cells; Dissolution; Drug absorption; Microsphere; Nasal delivery

Indexed keywords

GENTAMICIN; HYALURONIC ACID; KZ 60254; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; DRUG SOLUBILITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MEASUREMENT; PHARMACY; RESPIRATORY EPITHELIUM;

EID: 0036146377     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Nasal delivery: Not to be sniffed at
2. Nasal delivery systems and their effect on deposition and absorption
3. Nasal and pulmonary drug delivery systems
4. Advances in nasal drug delivery devices and packaging
5. Further developments in nasal drug delivery
6. Mathematical modelling of deposition and disposition of drugs administered via the nose
7. Absorption, clearance and dissolution in the lung
8. Solute absorption from the airways of the isolated rat lung. I. The use of absorption data to quantify drug dissolution or release in the respiratory tract
9. Commentary on the FDA draft guidance for bioequivalence studies for nasal aerosols and nasal sprays for local action: An industry view
10. The biopharmaceutical aspects of nasal mucoadhesive drug delivery
11. Airway surface liquid: A barrierto diffusion
12. Toxicological implications of nasal formulations
13. Effects of formulation variables on nasal epithelial integrity: Biochemical evaluations
14. Aerodynamic assessment of fine particles: Apparatus A (glass impinger)
15. In vitro cell models to study nasal mucosal permeability and metabolism
16. Nasal drug delivery, Evaluation of an in vitro model using porcine nasal mucosa
17. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery
18. Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells
19. Formulation of inhaled medicines: Effect of delivery vehicle on 16HBE14o- bronchial epithelial cells
20. Human airway epithelial cell lines for in vitro drug transport and metabolism studies
21. Differences in drug absorption across bronchial and gastrointestinal drug absorption models
22. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan
23. Effect of anisotonic conditions on the transport of hydrophilic model compounds across monolayers of human colonic cell lines
24. Anatomy, physiology and function of the nasal cavities in health and disease
25. Intranasal delivery of peptides and proteins
26. Microspheres as nasal drug delivery systems
27. The controlled delivery of drugs to the lung